09/24/2020
6:49 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Five Prime Therapeutics (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/01/2020
5:07 AM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/24/2020
12:46 PM | Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2020
11:17 AM | Five Prime Therapeutics (Filer)
| Form CT ORDER
| |
05/20/2020
3:14 PM | Five Prime Therapeutics (Issuer)
RINGO WILLIAM R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/18/2020
7:02 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Five Prime Therapeutics (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/18/2020
6:51 PM | BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
Five Prime Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/18/2020
9:36 AM | Five Prime Therapeutics (Issuer)
Jensen Peder (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2020
4:49 PM | Five Prime Therapeutics (Issuer)
Nicholson Garry A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2020
4:46 PM | Dhingra Kapil (Reporting)
Five Prime Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
05/15/2020
4:43 PM | BERGER FRANKLIN M (Reporting)
Five Prime Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2020
4:33 PM | Five Prime Therapeutics (Issuer)
SCHAFER CAROL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2020
4:30 PM | Five Prime Therapeutics (Issuer)
Lyons-Williams Lori (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2020
3:10 PM | Five Prime Therapeutics (Filer)
| Form DEFA14A
| |
04/20/2020
6:55 PM | Five Prime Therapeutics (Issuer)
RINGO WILLIAM R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/14/2020
3:38 PM | Civik Thomas (Reporting)
Five Prime Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/14/2020
8:06 AM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/06/2020
3:06 PM | Five Prime Therapeutics (Filer)
| Form 8-K/A
| |
04/03/2020
5:04 AM | Five Prime Therapeutics (Filer)
| Form DEF 14A
| |
03/23/2020
11:11 AM | Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2020
2:26 PM | Five Prime Therapeutics (Issuer)
RINGO WILLIAM R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2020
5:32 PM | Five Prime Therapeutics (Issuer)
Smith David V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2020
7:35 AM | Five Prime Therapeutics (Issuer)
White David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2020
3:11 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2020
7:29 PM | Five Prime Therapeutics (Issuer)
Sarena Francis Willard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2020
7:22 PM | Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2020
7:13 PM | Five Prime Therapeutics (Issuer)
White David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2020
7:26 PM | Five Prime Therapeutics (Issuer)
RINGO WILLIAM R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2020
8:28 AM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2020
3:20 PM | Five Prime Therapeutics (Subject)
GREAT POINT PARTNERS LLC (Filed by)
| Form SC 13G/A
| |
02/06/2020
5:51 PM | Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2020
5:49 PM | Five Prime Therapeutics (Issuer)
Sarena Francis Willard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2020
3:10 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/21/2020
12:34 PM | Five Prime Therapeutics (Issuer)
RINGO WILLIAM R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2020
12:33 PM | Five Prime Therapeutics (Issuer)
RINGO WILLIAM R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2020
5:16 AM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2019
4:59 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Five Prime Therapeutics (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2019
3:31 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2019
5:39 PM | Five Prime Therapeutics (Issuer)
RINGO WILLIAM R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2019
5:13 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Five Prime Therapeutics (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2019
8:49 AM | Five Prime Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A
| |
12/04/2019
5:28 PM | BERGER FRANKLIN M (Reporting)
Five Prime Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2019
4:59 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Five Prime Therapeutics (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2019
3:07 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2019
11:44 AM | Five Prime Therapeutics (Issuer)
RINGO WILLIAM R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2019
11:11 AM | Five Prime Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A
| |
11/08/2019
4:17 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Five Prime Therapeutics (Subject)
| Form SC 13G/A
| |
11/07/2019
6:22 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Five Prime Therapeutics (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2019
4:16 PM | Five Prime Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2019
3:11 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2019
5:24 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Five Prime Therapeutics (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/25/2019
4:43 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Five Prime Therapeutics (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/21/2019
4:30 PM | Five Prime Therapeutics (Issuer)
RINGO WILLIAM R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2019
3:12 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2019
3:06 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/08/2019
6:30 PM | Five Prime Therapeutics (Issuer)
RINGO WILLIAM R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2019
4:40 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Five Prime Therapeutics (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2019
3:42 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Five Prime Therapeutics (Issuer)
LAMPERT MARK N (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/02/2019
3:42 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Five Prime Therapeutics (Subject)
| Form SC 13G/A
| |
09/19/2019
3:32 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/04/2019
12:20 PM | Five Prime Therapeutics (Issuer)
Williams Lewis T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2019
12:18 PM | Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2019
12:15 PM | Five Prime Therapeutics (Issuer)
Sarena Francis Willard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2019
12:12 PM | Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2019
11:15 PM | Five Prime Therapeutics (Filer)
| Form EFFECT
| |
08/22/2019
5:50 PM | Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2019
3:07 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/19/2019
3:47 PM | Five Prime Therapeutics (Filer)
| Form S-3/A
| |
08/07/2019
7:48 PM | Five Prime Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2019
3:17 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/02/2019
9:17 AM | Five Prime Therapeutics (Filer)
| Form CT ORDER
| |
08/02/2019
9:11 AM | Five Prime Therapeutics (Filer)
| Form CT ORDER
| |
08/02/2019
9:00 AM | Five Prime Therapeutics (Filer)
| Form CT ORDER
| |
07/31/2019
3:10 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2019
3:08 PM | Five Prime Therapeutics (Subject)
| Form SC TO-I/A
| |
07/10/2019
1:58 PM | Five Prime Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A
| |
07/01/2019
5:08 AM | Five Prime Therapeutics (Subject)
| Form SC TO-I
| |
06/28/2019
3:07 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2019
3:35 PM | Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2019
3:30 PM | Five Prime Therapeutics (Issuer)
Sarena Francis Willard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2019
3:28 PM | Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2019
3:25 PM | Five Prime Therapeutics (Issuer)
Smith David V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2019
3:10 PM | Five Prime Therapeutics (Issuer)
Lyons-Williams Lori (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2019
3:08 PM | Five Prime Therapeutics (Issuer)
Lyons-Williams Lori (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/24/2019
3:11 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2019
5:37 PM | Five Prime Therapeutics (Issuer)
Nicholson Garry A (Reporting)
| Form 3/A
| |
06/12/2019
5:28 PM | Five Prime Therapeutics (Issuer)
Williams Lewis T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2019
5:26 PM | Five Prime Therapeutics (Issuer)
SCHAFER CAROL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2019
5:23 PM | Five Prime Therapeutics (Issuer)
RINGO WILLIAM R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2019
5:21 PM | BERGER FRANKLIN M (Reporting)
Five Prime Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2019
5:18 PM | Five Prime Therapeutics (Issuer)
Nicholson Garry A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2019
5:15 PM | Five Prime Therapeutics (Issuer)
Jensen Peder (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2019
5:11 PM | Dhingra Kapil (Reporting)
Five Prime Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2019
3:09 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2019
12:53 PM | Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2019
5:42 PM | Five Prime Therapeutics (Issuer)
SCHAFER CAROL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2019
5:34 PM | Five Prime Therapeutics (Issuer)
SCHAFER CAROL (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/16/2019
5:29 PM | Five Prime Therapeutics (Issuer)
Irving Bryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2019
3:11 PM | Five Prime Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2019
4:11 PM | Five Prime Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
